Radioembolisation with Yttrium-90 microspheres: An effective treatment modality for unresectable liver metastases

Journal of Medical Imaging and Radiation Oncology

Volumn 57, Issue 1, 2013, Pages 72-80

  Bester, Lourens ^a   Meteling, Baerbel ^a   Pocock, Nicholas ^a   Saxena, Akshat ^a   Chua, Terence C ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

chemotherapy refractory; colorectal cancer; liver metastasis; radioembolisation; Yttrium 90 microspheres

Indexed keywords

MICROSPHERE Y 90; RADIOACTIVE MICROSPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ABDOMINAL PAIN; AGED; ARTICLE; CHEMOEMBOLIZATION; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; GASTRITIS; HUMAN; LETHARGY; LIVER DISEASE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION INDUCED EMESIS; RADIATION INDUCED LIVER DISEASE; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; STOMACH ULCER; SURVIVAL TIME;

AGED; COMORBIDITY; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; NEW SOUTH WALES; PREVALENCE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84873371235     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2012.02459.x     Document Type: Article

References (38)

1. Hoffmann R, Jakobs T, Kubisch C, et al. Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-is it feasible? Eur J Radiol 2010; 74: 199-205.
2. Lewandowski R, Geschwind J-F, Liapi E, Salem R,. Transcatheter intraarterial therapies: rationale and overview. Radiology 2011; 259: 641-657.
3. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
4. Giantonio J, Catalano P, Meropol N, et al. Bevacizumab in combination with oxaliplatin, fluorouracil and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25: 1539-1544.
5. Alberts S, Horvath W, Sernfeld W,. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 2005; 23: 9243-9249.
6. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016.
7. Salem R, Lewandowski R, Gates V, et al. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 2011; 22: 265-278.
8. Riaz A, Lewandowski R, Kulik L, et al. Complications following radioembolization with Yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 2009; 20: 1121-1130.
9. Campbell AM, Bailey IH, Burton MA,. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic Yttrium-90 microsphere therapy. Phys Med Biol 2000; 45: 1023-1033.
10. Tehranipour N, Al-Nahhas A, Canelo R, et al. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology. Clin Nucl Med 2007; 32: 371-374.
11. 90Yttrium microsphere treatment of liver cancer. J Med Imaging Radiat Oncol 2010; 54: 178-187.
12. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12: 1711-1720.
13. Sharma RA, Van Hazel GA, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using Yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007; 25: 1099-1106.
14. Hendlisz A, Van den Eynde M, Peeters M, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with Yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol 2010; 28: 1-8.
15. Cosimelli M, Golfieri R, Cagol P, et al. Multi-centre phase II clinical trial of Yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 2010; 103: 324-331.
16. Jakobs T, Hoffmann R-T, Fischer T, et al. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 2008; 19: 683-690.
17. Coldwell D, Kennedy A, Nutting C,. Use of Yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 2007; 69: 800-804.
18. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 2007; 18: 621-628.
19. 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 2006; 17: 1251-1278.
20. Kennedy AS, Salem R, Murthy R, et al. Recommendations for radioembolization of hepatic malignancies using Yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68: 13-23.
21. Kennedy A, Salem R,. Radioembolization (Yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer 2010; 16: 163-175.
22. 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 2006; 17: 1425-1439.
23. 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007; 30: 571-592.
24. Louie J, Kothary N, Kuo W, et al. Incorporating cone-beam CT into the treatment planning for Yttrium-90 radioembolization. J Vasc Interv Radiol 2009; 20: 606-613.
25. Bester L, Meteling B, Nicholas P, et al. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J Vasc Interv Radiol 2012; 23: 96-105.
26. Seidensticker M, Ruehl R, Kraus P, et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Intervent Radiol 2012; 35: 1066-1073.
27. Cianni R, Urigo C, Notarianni E, et al. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol 2009; 32: 1179-1186.
28. Murthy R, Xiong H, Nunez R, et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 2005; 16: 937-945.
29. Jakobs TF, Hoffmann R-T, Dehm K, et al. Hepatic Yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008; 19: 1187-1195.
30. 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 2009; 74: 1494-1500.
31. 90Y- microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006; 65: 412-425.
32. Wasan H, Kennedy A, Coldwell D, Sangro B, Salem R,. Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases. Am J Clin Oncol 2012; 35: 293-301.
33. 90Y microspheres-safety, efficacy, and survival. Radiology 2008; 247: 507-515.
34. Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007; 18: 553-562.
35. Atassi B, Bangash A, Lewandowski R, et al. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol 2008; 19: 691-697.
36. Breedis C, Young G,. The blood supply of neoplams in the liver. Am J Pathol 1954; 30: 969-974.
37. Adam R,. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003; 14 (Suppl 2): ii13-16.
38. Khatri V, Chee K, Petrelli N,. Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 2007; 16: 71-83.